Cancer antigen-specific T-cell receptor gene, peptide encoded by the gene, and use of them

Details for Australian Patent Application No. 2008222061 (hide)

Owner International Institute of Cancer Immunology, Inc.

Inventors Sugiyama, Haruo

Agent Davies Collison Cave

Pub. Number AU-A-2008222061

PCT Pub. Number WO2008/108257

Priority 2007-054215 05.03.07 JP

Filing date 28 February 2008

Wipo publication date 12 September 2008

International Classifications

C12N 15/00 (2006.01) Mutation or genetic engineering

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 35/00 (2006.01) Antineoplastic agents

C07K 14/725 (2006.01) Peptides having more than 20 amino acids

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

G01N 33/574 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for cancer

Event Publications

10 September 2009 PCT application entered the National Phase

  PCT publication WO2008/108257 Priority application(s): WO2008/108257

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008222067-Threaded joint for steel tubes

2008222039-Pesticidal composition and method for controlling a pest